Sharp Therapeutics Corp.
SHRX.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.39M | -1.09M | 559.10K | -3.25M | 454.20K |
| Total Depreciation and Amortization | 23.20K | 25.20K | 23.00K | 26.90K | 45.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 835.10K | 74.30K | -1.95M | 1.99M | -1.81M |
| Change in Net Operating Assets | 559.20K | -132.60K | 24.60K | -152.60K | -154.80K |
| Cash from Operations | -975.60K | -1.12M | -1.35M | -1.39M | -1.47M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 5.10K |
| Cash from Investing | -- | -- | -- | -- | 5.10K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -50.00K | -50.00K | -50.00K | -50.00K | -286.80K |
| Issuance of Common Stock | 34.40K | 6.60K | 2.48M | -- | 4.96M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 400.00K |
| Cash from Financing | -15.60K | -43.40K | 2.43M | -50.00K | 5.08M |
| Foreign Exchange rate Adjustments | -44.80K | 5.10K | 45.90K | -26.00K | 6.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -400.00K |
| Net Change in Cash | -1.04M | -1.16M | 1.13M | -1.47M | 3.22M |